Braskem S.A.

NYSE:BAK

Chemicals

Basic Materials
$0.86 -11.76%

-$0.40 today

Market cap
$343.37M
Beta
0.67
P/E (TTM)
-0.7
EPS (TTM)
-$11.45
52W Low $2.32High $5.40

Volume 3.32M

Average 2.97M

BAK Other Financing Activities

Financing cash flows not reported separately.

Braskem S.A.NYSE: BAK

Other Financing Activities · Q1 FY2026 · quarter ended Mar 2026

Other financing activities turns negative

Q1 FY2026 other financing activities was -R$200.18M, compared with R$5M a year earlier. Trailing-twelve-month other financing activities was -R$427.96M.

Context

  • Other financing activities amounted to 0.1% of revenue in FY2025, unchanged from a year earlier.
  • Other financing activities increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly other financing activities holds near -R$200.18M or moves back toward the trailing-twelve-month quarterly average of -R$106.99M.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
-R$200.18M-0.3% QoQ
Last fiscal yearDec 2025
-R$63.8M-267.9% YoY
LTMMar 2026
-R$427.96M-1628.4% YoY
Other Financing Activities past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-4103.6%——
1 year-267.9%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Other Financing Activities history

BRL · from the cash flow

Latest · FY2025
(63.8M) BRL
Year-over-year change
-267.9%

Other Financing Activities vs competitors

How BAK compares with its peers on the latest reported figures

  • Peers report in different currencies, so other financing activities is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -1628.4% is the lowest of 11, against a peer median of +67.1%.
  • Other financing activities amounts to 0.6% of revenue for BAK, versus a peer median of 6.4%.
BAK Competitors
Other Financing Activities for BAK and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ECVTEcovyst Inc.LTM Mar 2026$526.09M USD+1263.7%—64.2%
BAKBraskem S.A.LTM Mar 2026R$427.96M BRL-1628.4%—0.6%
WLKPWestlake Chemical Partners LPLTM Mar 2026$282.35M USD-6.1%-8.4%22.9%
ASPIASP Isotopes Inc. Common StockLTM Mar 2026$44.86M USD+686.2%-35.0%166.6%
REXREX American Resources CorporationLTM Apr 2026$35.65M USD+91.2%+0.8%5.4%
MUXMcEwen Mining Inc.LTM Mar 2026$17.36M USD+1428.2%—7.4%
NAKNorthern Dynasty Minerals Ltd.LTM Mar 2026CA$8.7M CAD+2370.4%——
CNLCollective Mining Ltd.LTM Mar 2026$3.3M USD-155.0%+105.5%—
SCLStepan CompanyLTM Mar 2026$2.04M USD+43.1%-3.6%0.1%
UANCVR Partners, LPLTM Mar 2026$1.19M USD-52.9%+12.3%0.2%
RYAMRayonier Advanced Materials Inc.LTM Mar 2026$256K USD-96.5%—0.0%
Peer median (excluding BAK) —+67.1%-1.4%6.4%

Competitors are the stored peer set for BAK. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

BRL
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income13.98B47M(4.58B)(17.73B)(9.69B)
Depreciation & Amortization4.87B4.73B5.21B4.95B4.58B
Deferred Income Tax00000
Stock-Based Compensation14.39M010M00
Change in Working Capital(12.48B)3.97B(3.96B)557M(1.71B)
Accounts Receivables(2.18B)4.65B72M609M321.56M
Inventory(7.57B)2.14B1.81B(181M)2.88B
Accounts Payables0514M0384M(2.3B)
Other Working Capital(2.73B)(3.34B)(5.84B)(255M)(2.61B)
Other Non-Cash Items8.39B203M1.05B14.66B2.72B
Operating Cash Flow14.79B8.95B(2.27B)2.44B(4.09B)
Capital Expenditures(3.42B)(4.85B)(4.53B)(3.76B)(3.07B)
Acquisitions (Net)0(107M)(78M)203M100M
Purchases of Investments0(64.97M)00(77.45M)
Sales of Investments0000105.88M
Other Investing Activities40.65M72.97M83M73M0
Investing Cash Flow(3.38B)(4.95B)(4.53B)(3.49B)(2.94B)
Debt Repayment(10.97B)1.55B8.28B437M3.2B
Common Stock Issued00000
Common Stock Repurchased00000
Dividends Paid(5.99B)(1.35B)(7M)(6M)0
Other Financing Activities021M596M38M(63.8M)
Financing Cash Flow(16.97B)225M8.87B469M3.13B
Effect of Forex Changes377.53M(444M)(355M)1.38B1.1B
Net Change in Cash(5.18B)3.79B1.72B799M(2.79B)
Free Cash Flow11.37B4.1B(6.8B)(1.33B)(7.16B)

Braskem S.A.

NYSE:BAK

Intrinsic Alpha fair value

Locked

Current Price

$0.86

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.